Table 1.
Stratification according to risk for recurrence prior to randomization according to predefined groups and distribution of BEXIDEM and BCG among the risk groups.
| Group | TNM Classification | Number of Tumors | BEXIDEM® | BCG |
|---|---|---|---|---|
| A | Ta Grade 1 T1 Grade 1 |
Single or multiple Single |
26 | 29 |
| B | Ta Grade 2 T1 Grade 1 T1 Grade 2 |
Single or multiple Multiple Single |
26 | 26 |
| C | Ta Grade 3 T1 Grade 2 |
Single or multiple Multiple |
23 | 23 |